Publications

5808 Results

Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with early-stage aggressive B-cell lymphoma: Southwest Oncology Group Study 0014. [PMID 18413640]

Authors
DO Persky;JM Unger;CM Spier;B Stea;M LeBlanc;MJ McCarty;LM Rimsza;RI Fisher;TP Miller
Journal / Conference
Journal of Clinical Oncology 26(14)2258-2263
Year
2008
Research Committee(s)
Lymphoma
Study Number(s)
S0014

Treatment options for muscle invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin: report of Southwest Oncology Group trial 8733 [PMID18404692]

Authors
CS Higano;CM Tangen;WA Sakr;J Faulkner;SE Rivkin;FJ Meyers;M Hussain;LH Baker;KJ Russell;D Raghavan;ED Crawford
Journal / Conference
Cancer 112(10):2181-2187
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8733

Maintenance gefitinib or placebo following concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small cell lung cancer: A phase III Southwest Oncology Group study S0023 [PMID18378568]

Authors
K Kelly;K Chansky;LE Gaspar;KS Albain;J Jett;YC Ung;DHM Lau;DR Gandara
Journal / Conference
Journal of Clinical Oncology 26(15)2450-2456
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0023

Detection of copy number alterations in malignant melanoma by both a panel of 16 DNA FISH probes and array comparative genomic hybridization: a Southwest Oncology Group study (S9431) [PMID 18483359]

Authors
SR Moore;DL Persons;JA Sosman;D Bobadilla;V Bedell;DD Smith;SR Wolman;RJ Tuthill;J Moon;VK Sondak;ML Slovak
Journal / Conference
Clinical Cancer Research 14(10):2927-2935
Year
2008
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9431

Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials [PMID18202421]

Authors
PN Lara Jr;MW Redman;K Kelly;MJ Edelman;SK Williamson;JJ Crowley;DR Gandara
Journal / Conference
Journal of Clinical Oncology 26(3):463-467
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0003, SWOG-9509, S9806

Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer [PMID18172274]

Authors
AL Sabichi;SP Lerner;EN Atkinson;HB Grossman;NP Caraway;CP Dinney;DF Penson;S Matin;A Kamat;LL Pisters;DW Lin;RL Katz;DE Brenner;GP Hemstreet III;M Wargo;A Bleyer;WH Sanders;JL Clifford;HL Parnes;SM Lippman
Journal / Conference
Clinical Cancer Research 14(1):224-229
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9460

Total body irradiation, etoposide, cyclophosphamide and autologous peripheral blood stem cell transplantation followed by randomization to therapy with Interleukin-2 versus observation for patients with non-Hodgkin's lymphoma: Results of a Phase III randomized trial by the Southwest Oncology Group (SWOG 9438) [PMC2288718; PMID18256325]

Authors
JA Thompson;RI Fisher;M LeBlanc;SJ Forman;OW Press;JM Unger;AP Nademanee;PJ Stiff;SH Petersdorf;A Fefer
Journal / Conference
Blood 111(8):4048-4054
Year
2008
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9438

Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium [PMID18501081]

Authors
TM Beer;B Goldman;CR Nichols;DP Petrylak;M Agarwal;CW Ryan;ED Crawford
Journal / Conference
Clinical Genitourinary Cancer 6(1):36-39
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
S0306

Does the level of prostate cancer risk affect cancer prevention with finasteride?

Authors
IM Thompson;CM Tangen;HL Parnes;SM Lippman;CA Coltman Jr
Journal / Conference
Urology 71(5):854-857
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID18455628
PMC
PMC2692669
Study Number(s)
SWOG-9217

Prostate-specific antigen progression (PSA-P) predicts overall survival (OS) in patients (pts) with metastatic prostate cancer (PC): data from S9346 and S9916.

Authors
B Goldman;M Hussain;C Tangen;C Higano;DP Petrylak;NJ Vogelzang;ED Crawford
Journal / Conference
Journal of Clinical Oncology 26(15s):253s, #5015
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346, S9916